Ned D. Heindel (Chair) is the H. S. Bunn Chair Professor of Chemistry at Lehigh University and a consultant on drug development for Azevan Pharmaceuticals. Dr. Heindel has graduated 40 doctoral students, most of whom have entered academia or the health care industry. He has engaged in contract research and development (R&D) for Astra-Zeneca, Air Products, BMS, Merck, J&J, and DuPont, as well as for eight venture capital start-up firms. At Lehigh University, he teaches general, organic, and medical chemistry and organic mechanisms along with three web-mounted graduate courses in a Distance Education program. Dr. Heindel is a graduate of Lebanon Valley College (BS, 1959), the University of Delaware (PhD, 1963), and Princeton University (postdoc, 1964). He taught at the University of Delaware, Marshall University, and Ohio University before joining the faculty of Lehigh University. Dr. Heindel also served as President of the American Chemical Society (ACS) in 1994.
Montgomery Alger received BS and MS degrees in chemical engineering from the Massachusetts Institute of Technology and a PhD in chemical engineering from the University of Illinois at Urbana-Champaign. Dr. Alger serves on the Chemical Engineering Advisory Councils at Lehigh University, Georgia Institute of Technology, and the University of California-Santa Barbara. He served as a board member for the American Institute of Chemical Engineers and is a member of the National Academy of Engineering. Dr. Alger is a certified Six Sigma Master Black Belt.
William Bullock is Senior Director, Research Business Operations, Bristol-Myers Squibb (BMS). Dr. Bullock received his PhD from Emory University in organic chemistry. After completing a chemistry postdoctoral fellowship with National Academy of Sciences member Prof. Larry Overman (University of California, Irvine), he accepted a position as laboratory supervisor with Bayer Pharmaceutical. During his 15-year career with Bayer, he contributed to and led a variety of successful research programs in Connecticut and Germany. By 2002, Dr. Bullock was appointed to the position of Director, contributing chemistry leadership to the diabetes drug discovery portfolio. In addition, he reexamined and redefined several global R&D processes. These efforts included a fundamental transformation of the early drug candidate selection process, resulting in increased Phase 1 success; global harmonization of research practices and roles, allowing for the creation of a web-based portfolio management tool; and deployment of electronic notebooks in the United States.
In 2007, Dr. Bullock joined BMS as Director in Research Business Operations. Today, he has business operations responsibilities for five departments within research and is chair of the Research Technology Evaluation and Sustainability Committee and of the Chemistry Safety Committee. He has either contributed to or led several notable projects, including centralization of all final drug candidate purification, incorporation of safety warning systems into the BMS electronic notebook system, and transformation
of lab and office design from high customization to high flexibility, and the Global R&D Footprint Committee.
Mark Cesa is a physical organic/organometallic chemist with research interests in homogeneous and heterogeneous catalysis and organic reaction kinetics and mechanisms. He studied chemistry at Princeton University, where he earned an AB in 1974. He earned his MS (1977) and PhD (1979) in organic chemistry at the University of Wisconsin-Madison, under the supervision of Prof. Charles P. Casey. Dr. Cesa has recently retired from his position as Process Chemistry Consultant with INEOS Nitriles, Naperville, Illinois, where he was responsible for process chemistry research and support for INEOS Nitriles manufacturing plants. Dr. Cesa was the 2014-2015 President of the International Union of Pure and Applied Chemistry. He also served as chair of the IUPAC Committee on Chemistry and Industry, where he coordinated the IUPAC Safety Training Program. Dr. Cesa is currently chair of the American Chemical Society Committee on Science and has served on the ACS Committee on Chemical Safety.
Thomas Edgar is the George T. and Gladys H. Abell Chair in Chemical Engineering at the University of Texas (UT) at Austin. He received his BS in chemical engineering from the University of Kansas and PhD from Princeton University. Dr. Edgar worked as a process engineer with the Continental Oil Company before joining UT’s faculty in 1971. He served as Department Chair of Chemical Engineering (1985-1993), Associate Dean of Engineering (1993-1996), and Associate Vice President for Academic Computing (1996-2001) at UT-Austin. He recently became Director of the UT Energy Institute (2012).
For the past 40 years Dr. Edgar has concentrated his academic work in process modeling, control, and optimization. He has published more than 450 articles and book chapters in the above fields applied to separations, chemical reactors, energy systems, and semiconductor manufacturing. He has supervised the thesis research of more than 45 MS and 80 PhD students. He also co-directs the Texas-Wisconsin-California Control Consortium, which involves 12 companies.
Patrick J. Y. Lim is Professor and former Chair (2004-2011) of the Department of Chemistry at the University of San Carlos (USC) in Cebu City, Philippines. He earned his PhD in chemistry (2000) at the University of Melbourne under the supervision of Assoc. Prof. Charles G. Young, investigating novel reactions of metal–sulfur compounds with activated alkynes. He served as an accreditor of the Philippines Accrediting Association of Schools, Colleges and Universities and was also a member of the Philippine Commission on Higher Education Technical Committee for Chemistry (2007-2009). He has served as editor of The Philippine Scientist, a multidisciplinary ISI-listed journal published by USC Press, since 2008. Dr. Lim has been engaged in chemical safety and security in various capacities from professional meetings in Spiez, Switzerland, and at the OPCW Headquarters in The Hague, the Netherlands, to conducting trainings in Karachi, Pakistan, and Taiz, Yemen, as well as in the central and southern Philippines.
Kenneth Moloy is currently a Program Director at the National Science Foundation. He received a PhD in inorganic chemistry from Northwestern University in 1984 and a BS in chemistry from Indiana University in 1980. Following graduate school he joined Union Carbide’s Technical Center in South Charleston, West Virginia, working in long-range R&D. In 1995 he moved to the DuPont Central Research and Development in Wilmington, Delaware. Dr. Moloy left DuPont in 2016 as a Research Fellow. Dr. Moloy’s expertise lies in the areas of organometallic chemistry, catalysis, organic chemistry, and process chemistry. He has chaired the Gordon Research Conference on Organometallic Chemistry and also the Organo-
metallic Subdivision of the ACS Division of Inorganic Chemistry. Dr. Moloy recently participated on a National Academy of Sciences (NAS) committee to revise Prudent Practices in the Laboratory. Dr. Moloy is also a current member of the National Academies of Sciences, Engineering, and Medicine’s Chemical Sciences Roundtable.
Supawan Tantayanon is a Professor of Chemistry of the Faculty of Science, Chulalongkorn University, Thailand. She received her BSc Honor (chemistry) from Chulalongkorn University, MSc (organic chemistry) from Mahidol University, Thailand, and PhD (organic chemistry) from Worcester Polytechnic Institute, Massachusetts. She initiated and became the first Director of three new academic programs of Chulalongkorn University, namely the Applied Chemistry (BSc program), the Petrochemistry and Polymer Science (MSc and PhD program), and the Technopreneurship and Innovation Management Program (MSc and PhD program). Her research interest involves organic and polymer syntheses but has recently focused more on green chemistry and its commercialization.
Dr. Tantayanon served as President of the Polymer Society of Thailand (1997-2003), Pacific Polymer Federation (2002-2003), Chemical Society of Thailand (2007-2012), and Federation of Asian Chemical Societies (2011-2013). Currently she is a member of the National Hazardous Materials Committee, and the Council of Science and Technology Professionals of Thailand.
Camly Tran joined the Board on Chemical Sciences and Technology at the National Academy of Sciences, Engineering, and Medicine in 2014 as a postdoctoral fellow after receiving her PhD in chemistry from the Department of Chemistry at Brown University and is currently an Associate Program Officer. During her time at Brown, she received various honors including the Elaine Chase Award for Leadership and Service, American Chemical Society Global Research Exchanges Education Training Program, and the Rhode Island NASA grant. Dr. Tran completed the workshop summary Mesoscale Chemistry and consensus studies Spills of Diluted Bitumen from Pipelines and Effective Chemistry Communication in Informal Environments. Dr. Tran is currently supporting activities on the changing landscape of hydrocarbon feedstocks for chemical production, chemistries of the microbiome, and standard operating procedures for safe and secure handling, management, and storage of chemicals in chemical laboratories.
Claire Ballweg joined the National Academy of Sciences, Engineering, and Medicine in April of 2015 as a Senior Program Assistant on the Board on Environmental Studies and Toxicology after receiving her MS in ecological applications from Imperial College London. In January 2016, she assumed the role of Program Coordinator for the Board on Chemical Sciences and Technology. During her time at Imperial College, she completed a thesis analyzing complex global datasets using Geographic Information Systems to develop a model for identifying appropriate and ideal tropical forest conservation areas. She is currently supporting activities on the role of chemistry in human, marine, and geological microbial communities, and standard operating procedures for safe and secure handling, management, and storage of chemicals in chemical laboratories.
This page intentionally left blank.